Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

virus * vulnerability 195

-- Keyword
line immunodeficiency (FIV): Evaluation of its virulenc
mes of hepatitis B and C (HBV, HCV) during HIV infectio
man immunodeficiency viruses involves a highly conserved

erisation of nef deleted
ds/HIV-1 subtypes and
duction/NSI and not SI
ge and T cell line tropic
ad of HIV and hepatitis
CR)/Modulation of DNA
nfection by enveloped
fections (HIV and other
e epidemiology of slow
Italy/HIV infection and
emia for retinitis versus
oads than patients with
Prolonged recovery of

from three long-term non-pr
specific for Dutch drug users
enhance cell proliferation an
by a bivalenet subtype B/E
through the use of injection r
regulatory regions by HIV-1
/Carrageenan based formule
) in France/Residual risk of t: New findings on human imr
visceral leishmaniasis in a Mediterra
disease in patients with acti)
KS/Patients with cutaneous
Kaposi's sarcoma in two All

Abstra
e/A th
in/Pra
envel
rogres
Sin het
d beta
vaccin
ieedle
Tat: Tr
ations
ransfu
nunod
nean
ve CM
Kapo
DS pat

n project/Focusing our vision, achieving results: Unintended cons
ation of patient reported measures in cytomegalovirus retinit
en (MSM): The Bela Vista Cohort Study, Sao Paulo, Brazil/Sex
Paulo, Brazil: The Bela Cohort Study/Prevalence and incide
V vaccines/Cohort Bela: Feasibility of efficacy trials on HIV va
sex with men: The Bela cohort, Sao Paulo, Brazil/Hepatitis C
incarcerated women in Vit6ria, Brazil/Correlates of HIV infection
in a reference center in, Brazil/Profile of heterosexual cou
cation and counselling: Vital components in a vaccine trial prepara
n Uganda/The media - element in HIV/AIDS prevention in Ug
ve children in Tanzania/ Vitamin A supplements and mortality amo
eiro, Brazil/Analysis of vitamin A and E plasma levels in HIV+ ex(WIHS)/Association of A deficiency with cervical dysplasi
cording to initial serum A levels/Survival and infections in
les/The success of the service at the AIDS Council of Ne
ents of specific B-group vitamins in a cohort of HIV positive and ne
uced immune recovery vitritis in CMV retinitis patients is immune
of protease inhibitors in vitro /HIV maturation and stability in the pr
ease inhibitors (PIs)/In antiviral activity and pharmacokinetic
V protease inhibitors/In inhibition of cytochromes P-450 2D6
vidence to reconcile in and epidemiologic data on the role of
quent HIV-1 infection/In evidence of HIV-2 protection from su
atients - Based on in model/Ritonavir-containing dual prot
he developing world: In release studies/Sustained release a
-2+ individuals resist in infection with macrophage tropic HIVviduals/rlL-2 rescues in functions of lymphocytes from HIV-inf

ct --
60780
60806
11115
11140
13195
21175
21214
23243
31223
33155
33199
60738
22325
60191
60499
60510
60459
60713
23140
23367
43551
60753
23551
60707
14254
33259
170*/42331
12121
621*/22301
42363
42375
42352
15*/22240
11133
12339
12382
13334
21136
22350
23267
31154
31185

SKeyword
its effects on viral load ( ) and CD4 count/Changing highly
o free viral load assays: VLAP (the Viral Load Access Projec
ants for development of VLP-based anti-HIV-1 vaccine/Biorr
tain a regular supply of voluntarily donated blood/Formatio
ntary therapies by PHA enrolled in an observatio
participate in research/ Voluntary consent to participate in re

avior: Results from the
ia and women's needs/
Iling and testing study/
e to mandatory testing/
centre - A pilot project/
zania: Results from the

HIV counselling and testin
HIV counselling and testir
HIV counselling and testir
prenatal testing as an alte
HIV testing and model co
voluntary HIV counselling and testin

otypic HIV resistance in
g of the Shiloov tube/In
nts PMPA and PMEA in
on of HIV replication in
in sulfate (mCDS) 71 in
sistant HIV-1 isolates in
plants, Indocalamus, in
o different subtypes/In
eplication capacity in
uals after expansion in
fter gene transfert/In
ence of hydroxyurea in
d screening using an in
antiviral treatment, 1. In
rus type 1 replication in
or STD prevention/In
mmunosuppression in
sis of HIV-1 evolution in
munodeficiency virus in
autologous PBMCs ex
trol of HIV replication in
hibitors/Prediction of in
he intestinal mucosa in
ection of CD8+ T cells in
emokine coreceptors in
d immunodeficiency ex
s of cytomegalovirus in
y and HIV dementia/In
bacavir (1592, ABC) in
nd PMEA in vitro and in
ed by gene transfer: in
transfert/In vitro and in
rdant identical twins/In
ine levels modulated in
d the rationale for an ex
he impact of viral load (
(IDU)/lnitial viral load (
ndetectable viral load (

Abstra
active
t) and
nolecu
n of bl
nal da
asearc
ig stud
ng inZ
ig (VC
ernativ
unselli
ig stud

correlates with viral load response to 231*/32289

d, WI: Results from the HIV counselling and testing stud
n-anergic adults from a counselling and testing clinic in
rates: Results from the HIV counselling and testing stud
ecting drug users?/ls a confidential HIV test associated
Africa/Acceptability of HIV counselling and testing (VC
aphic study in the AIDS sector in Rio de Janeiro, Brazil/I
zania: Results from the HIV counselling and testing stud
ork! Results from the HIV counselling and testing (VC
tries: Results from the HIV counselling and testing stud
ntries: Results from the counselling and testing study/V
ective: Results from the HIV counselling and testing stud
Zambia/Same day HIV counselling and testing (VCT) i
ntries: Results from the HIV counselling and testing stud
ich individuals undergo HIV serologic testing in Puerto
cation, counselling and testing/A survey of women to de
tnership: Regional HIV service organisations working to
munities/Statutory and sector involvement in the develo
g factors that influence HIV testing in peri-urban popula
ifornia hotline supports volunteer-driven, client-centered service/
ve volunteer training kit/ Volunteer training resources: A comprehe
ing with PWA in Japan/ characteristics and responses t
hould a counsellor do if volunteer refuse to share his/her HIV test r
PLWH/As/Managing a caregivers program: Sustaining
rces: A comprehensive training kit/Volunteer training re
DA/Consolidation of a workforce for HIV/AIDS preventi
mitment and decreasing turnover in community-based A
oping an HIV and AIDS helpline training programme in r
e immigrant population/ Volunteerism withing the immigrant popul
ndemic (MAP) network: and collegiality for worldwid
ating perceived costs of volunteerism into personal and collective
/Sustaining the spirit of in Olongapo City for HIV/AI
mmunity-based ASOs/ Volunteers as stakeholders: Approaches t
anosine (ddl) in healthy volunteers /Evaluation of potential interact
ealthy male and female /A pharmacokinetic interaction
Uganda/Recruitment of into a randomized, placebo co
p120 antigen in healthy /Clinical response to HIV Thai
ommunity leaders and /Empowering and building com
HIV patients/Needs for willing to work with an organiza
ropout and burnout in -A longitudinal study/Predicto
y: A PK study in healthy (HV)/Ritonavir (RTV) low dosa
le oral doses in healthy /Pharmacokinetics of efaviren
fampin (RIF) in healthy /Pharmacokinetic interaction b
ceptability in a group of (men and women)/Female co
Iness/Support given to faced with a moving illness/Su
xperience/Doctors and working with HIV children: The
pr is not responsible for Vpr-induced cell death/Cell cycle G2 arre
ce transgenic for HIV-1 Vpr /T cell apoptosis in mice transgenic for
port: matrix antigen and are the key regulators/Molecular mec
on/Positive selection of in human immunodeficiency virus type
ppression in vitro/HIV-1 mediated immunosuppression in vitro/
e Preparedness Study ( VPS )/Feasibility of conducting HIV-1 vacci
iversification of nef and vpu in six hemophilia B patients after clona
s load declines to <500 vRNA copies/ml/Two-year durability of HI: Uganda's experience/ Vulnerability of women secretaries to HIV
nd reproductive failure/ to HIV, identity and reproduc
ble behaviour change/ of women youth which could
ations for interventions/ to HIV among disadvantage
tion/education project/ of sexual partners of deep-s
ps in northern Uganda/ of refugee women to HIV/AI
' wives to HIV infection/ of of soldiers' wives to HIV inf
tegy/School and AIDS: reduction as a preventive str

ict --
60178
60699
60715
23261
42390
14358
593*/24323
24324
133*/33269
43147
60139
13116
13165
13324
14107
23234
23310
24102
24135
592*/24321
24328
133*/33269
580*/33277
33282
33288
138*/43121
43561
44267
44276
60985
33550
34312
60251
24325
34262
34312
34332
60431
60663
24367
33444
34147
43205
60431
12374
12380
33219
33220
34164
34177
34330
42257
42269
42280
60028
60606
60610
11141
11142
381*/11144
11147
60689
43543
11146
12279
13460
13576
14202
23449
23533
44209
60038
60130

14106
14196
14203
14221
14321
23328
23366

HIV-1 antibody induction: Testing of t
and in vivo/Cellular pharmacology of
in combination with other anti-HIV ag
/Development and characterization of
/Two- and three-protease inhibitor co
/Anti-human immunodeficiency virus
drug susceptibility and sequence ana
/HIV-1 expressing the 3TC-associate
/Conserved function of PBMC from h
and in vivo antiviral effect of human in
/Enhanced activation of nucleoside a
model of the blood-cerebrospinal flui
activity/Multiple herbal therapy: A ne
/Human lactoferrin inhibits human im
anti-HIV-1 and HIV-2 virucidal proper
/HIV-1 Vpr mediated immunosuppres
vivo /Phylogeny-based analysis of HIV-1 e:The envelope gene/Evolutionary fat
infected with a recombinant canarypo
/Lack of evidence that /-chemokines
impairment of cytochrome P450-medi
/Evidence that beta-chemokines stim
/HHV-6-independent HIV-1-infection
correlates with HIV-1 disease progres: Role of viral tropism in pathogenesis i
in HIV infected patients versus transpl
proton MRS studies of HIV brain injury
/Phenotypic HIV resistance in vitro cor
/Cellular pharmacology of the antiviral
in immunodeficient mice (SCID) impla
antiviral effect of human interferon-/3 i
persistence of genetically modified, HI
by DNA vaccines/Chemokine levels
immunoadsorption therapy/Circulatin
VL) nadir on the change of antiretroviral th
) soon after seroconversion (SC) has no
) in response to antiretroviral therapy: A

41112
554*/41175
41195
41198
41201
41207
41211
41214
41249
41250
42262
42270
60205
60342
60370
60689
11190
11219
11243
12109
12390
21120
21130
8*/21134
21149
31202
32204
231*/32289
554*/41175
41243
41250
346*/42322
42324
60831
22368
23396
42154

iour and perception of vulnerability
na/Risk perception and
equences of HIV/AIDS
evention approach/The
dolescent sexuality and
tal transmission/Social
ssing susceptibility and

to HIV infection in men who h
in female adolescents from A
/The detribalisation of the Za
of women addressed: An HI
to HIV infection in Mumbai, I
in HIV prevention of perinatal
/The HIV epidemic in Ukrain